SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178879-20-000006
Filing Date
2020-02-07
Accepted
2020-02-07 07:01:01
Documents
16
Period of Report
2020-02-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k2620.htm   iXBRL 8-K 39972
2 EXHIBIT 99.1 exhibit99121.htm EX-99.1 22580
8 exhibit991image1a26.jpg GRAPHIC 127191
  Complete submission text file 0001178879-20-000006.txt   377812

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20200207.xsd EX-101.SCH 4612
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20200207_cal.xml EX-101.CAL 640
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20200207_def.xml EX-101.DEF 1490
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20200207_lab.xml EX-101.LAB 26138
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20200207_pre.xml EX-101.PRE 13596
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k2620_htm.xml XML 4302
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 20584509
SIC: 2834 Pharmaceutical Preparations